Skip to content

New Jersey · Nonprofit

NEUROLIPID RESEARCH FOUNDATION

NEUROLIPID RESEARCH FOUNDATION (New Jersey) receives grants from 2 organizations whose IRS filings report $14,500 to it, the largest being NATL CHRISTIAN CHARITABLE FDN INC ($10,000). 0 of them have funded it in more than one year, and 69% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.

Revenue FY2020
$1.1M
Funders on record
2
Grants received
$15k
Net assets
$-50471
0/2 repeat fundersgrants exceed reported revenue in one year
01What it does

What Neurolipid Research Foundation does

Mission

The corporation is organized exclusively for charitable, educational, scientific, religious, and cultural organizations purposes, including for such purposes, the making and distributions to organizations that qualify as exempt organizations under section 501(c)(3) of the internal revenue code, or corresponding section of any federal tax code.

As stated on its FY2020 Form 990.

Program

The organization performs research and works to find answers for neurological disease, especially those involving the brain.

The first program described on its most recent Form 990, which lists programs largest first by expense.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended.

100 = 20172017 Revenue 0 ($0) Expenses 100 ($15k) Net assets 100 ($151k)2018 Revenue 100 ($225) Expenses 209 ($32k) Net assets 79 ($119k)2019 Revenue 889 ($2k) Expenses 336 ($52k) Net assets 46 ($69k)2020 Revenue 475655 ($1.1M) Expenses 7708 ($1.2M) Net assets -33 ($-50471)
2017201820192020
Revenue (475655)Expenses (7708)Net assets (-33)

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2018 to 2019, from $137k to $87k (−37%).

$168k
$137k
$87k
$65k
2017201820192020
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2018
2019
2020
ContributionsProgram revenueInvestmentOther

Government-grant reliance: 2020 1%. Grants only. Government contracts and fees sit inside program revenue.

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 4 reported years ran a deficit.

−$15k
’17
−$32k
’18
−$50k
’19
−$120k
’20
0.3
months of
reserve
03Who funds it

Who funds it, year by year

2019 → 2020: the base held at 1 funder, grant income fell $10k → $5k.

1 of 2 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 69% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of NEUROLIPID RESEARCH FOUNDATION’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

NEUROLIPID RESEARCH FOUNDATION leans on a few funders — its largest provides 69% of grant income and the top three 100%; half comes from just 1 funder.

the vertical line marks half of all grant income — 1 funder to its left

69% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund NEUROLIPID RESEARCH FOUNDATION.

69%
largest funder
100%
top three
~2
effective funders

Largest funder’s share by year: 2019 100% · 2020 100% — broadly stable.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

69% of NEUROLIPID RESEARCH FOUNDATION's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $5k that is directly attributable, 100% of it comes from New Jersey funders.

NJ

Funder states come from each funder’s own filing. $10k arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Organizations like NEUROLIPID RESEARCH FOUNDATION

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In New Jersey

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

77% of spending goes to programs.

Program 77%Management 23%Fundraising 0%

Governance

3
board members
100%
independent
✓Conflict-of-interest policy–Whistleblower policy–Document retention✓Board reviewed the 990✓Audited financials

Public support

100%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 1 state

NJ

Screen this organization

A dated, signed PDF of the compliance screen for NEUROLIPID RESEARCH FOUNDATION: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds NEUROLIPID RESEARCH FOUNDATION?
NEUROLIPID RESEARCH FOUNDATION (New Jersey) receives grants from 2 organizations whose IRS filings report $14,500 to it, the largest being NATL CHRISTIAN CHARITABLE FDN INC ($10,000). 0 of them have funded it in more than one year, and 69% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
How many funders does NEUROLIPID RESEARCH FOUNDATION have?
IRS filings report 2 organizations giving $14,500 in grants to NEUROLIPID RESEARCH FOUNDATION.
Who is the largest funder of NEUROLIPID RESEARCH FOUNDATION?
NATL CHRISTIAN CHARITABLE FDN INC is the largest funder on record, with $10,000 in grants. The full list of funders is on this page.
How can an organization like NEUROLIPID RESEARCH FOUNDATION find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in New Jersey. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

Play a game about who funds Neurolipid Research →

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2020 (financials across 2017–2020), and the filings of 2 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing